ArriVent BioPharma
AVBP
10.52
-0.74
-6.57%
ArriVent BioPharma
US · AVBP
#3057 by market cap
Listed 2024
10.52
-0.74
-6.57%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 10 analysts
Buy
Avg price target 28.00 +166.2%
Price target rangecurrent 10.52
Low22.00
Avg28.00
High43.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-11 | Citi | -- | Buy | 23.00 |
| 2026-11-10 | JonesTrading | -- | Buy | 22.00 |
| 2026-11-10 | Truist Financial | -- | Buy | 24.00 |
| 2026-11-10 | Citi | -- | Buy | 23.00 |
| 2026-11-10 | H.C. Wainwright | -- | Buy | 27.00 |
| 2026-11-10 | Oppenheimer | -- | Buy | 25.00 |
| 2026-11-09 | BTIG | -- | Buy | 29.00 |
| 2026-10-28 | H.C. Wainwright | -- | Buy | 27.00 |
| 2026-10-27 | Truist Financial | -- | Buy | 21.00 |
| 2026-10-26 | BTIG | -- | Buy | 29.00 |
| 2026-10-26 | Truist Financial | -- | Buy | 21.00 |
| 2026-10-26 | Guggenheim | -- | Buy | 30.00 |
| 2026-10-26 | Oppenheimer | -- | Buy | 25.00 |
| 2026-10-25 | BTIG | -- | Buy | 29.00 |
| 2026-10-25 | Clear Street | -- | Buy | -- |
| 2026-10-23 | Citi | -- | Buy | 20.00 |
| 2026-10-20 | B. Riley Securities | -- | Buy | 29.00 |
| 2026-10-13 | H.C. Wainwright | -- | Buy | 27.00 |
| 2026-10-08 | H.C. Wainwright | -- | Buy | 27.00 |
| 2026-10-07 | Citi | -- | Buy | 20.00 |
| 2026-10-06 | BTIG | -- | Buy | 29.00 |
| 2026-09-15 | Truist Financial | -- | Buy | -- |
| 2026-09-15 | Guggenheim | -- | Buy | 45.00 |
| 2026-09-14 | LifeSci Capital | -- | Buy | 43.00 |
| 2026-09-14 | Citi | -- | Buy | 40.00 |
Price target trend monthly average, last 3 years
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
ArriVent BioPharma discussion 0 comments